查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1701862

2025 年至 2033 年灰指甲治疗市场报告（按疾病类型、治疗类型、药物类别、配销通路和地区）

Onychomycosis Treatment Market Report by Disease Type, Treatment Type, Drug Class, Distribution Channel, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

2024年全球灰指甲治疗市场规模达36亿美元。展望未来， IMARC Group预计到2033年市场规模将达到54亿美元，2025-2033年期间的成长率（CAGR）为4.5%。由于越来越多地接触公共游泳池以及使用紧身、受污染或脏污的衣服、鞋子、袜子等，这种真菌感染在成年人和千禧一代中的患病率不断上升，这主要推动了市场的发展。

甲癣是一种发生在手指甲和脚趾甲的真菌感染，可导致不适、慢性疼痛和毁容。甲癣的类型包括近端甲下型、白色表层型和远端甲下型。它是足癣患者常见的指甲感染，由多种生物引起，例如皮癣菌、酵母菌和非皮癣菌霉菌。甲癣的特征症状包括指甲形状变形、恶臭、颜色由白色到黄褐色变化、指甲质地脆弱、粗糙和易碎。通常透过钾、氧和氢 (KOH) 检查、指甲剪和指甲活检的培养和组织病理学检查来诊断，并透过雷射疗法、药物和光动力疗法进行治疗。

灰指甲治疗市场趋势：

甲癣、人类免疫缺陷病毒 (HIV)、糖尿病和周边动脉疾病 (PAD) 等慢性疾病的盛行率不断上升，是推动市场成长的关键因素之一。此外，老年人口的增加也为市场成长提供了动力，老年人更容易罹患循环系统疾病和免疫系统减弱。由于千禧世代和成年人更多地接触公共游泳池以及穿着紧身、受污染或脏污的衣服、鞋子和袜子，灰指甲病在千禧世代和成年人中也非常普遍。此外，可口服的水溶性抗真菌治疗溶液的开发也为市场成长提供了推动力。它们有助于预防继发性细菌感染并防止真菌生长。其他因素，包括广泛使用外用指甲油和药膏来保持指甲卫生，以及医疗保健基础设施的显着改善，预计将推动市场成长。

本报告回答的关键问题

  • 2024 年全球灰指甲治疗市场规模？ 2025-2033年全球灰指甲治疗市场的预期成长率是多少？
  • 推动全球甲癣治疗市场发展的关键因素有哪些？
  • COVID-19 对全球甲癣治疗市场有何影响？
  • 根据疾病类型，全球灰指甲治疗市场是如何分布的？
  • 根据治疗类型，全球甲癣治疗市场是如何分布的？
  • 根据配销通路，全球灰指甲治疗市场如何分布？
  • 全球灰指甲治疗市场的主要区域有哪些？
  • 全球甲癣治疗市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球甲癣治疗市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依疾病类型

  • 远端甲下甲癣
  • 近端甲下甲癣
  • 白色表浅性甲真菌病
  • 念珠菌性甲癣
  • 其他的

第七章：市场区隔：依治疗类型

  • 雷射治疗
  • 光动力疗法
  • 药物治疗

第八章：市场区隔：依药品类别

  • 烯丙胺
  • 唑类
  • 灰黄霉素
  • 其他的

第九章：市场区隔：按配销通路

  • 医院和诊所
  • 网上商店
  • 零售药局
  • 其他的

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Bausch Health Companies Inc.
    • Cipla Limited
    • Dr. Reddy's Laboratories
    • Galderma SA
    • GlaxoSmithKline PLC
    • Kaken Pharmaceutical Co. Ltd
    • Lumenis Ltd
    • Moberg Pharma AB
    • Novartis AG
    • Pfizer Inc.
    • The OTC Lab BV
Product Code: SR112025A4877

The global onychomycosis treatment market size reached USD 3.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.5% during 2025-2033. The rising prevalence of this fungal infection among adults and millennials due to the increased exposure to public swimming pools and the use of tight, contaminated, or soiled clothes, shoes, socks, etc., is primarily driving the market.

Onychomycosis is a fungal infection that occurs in the fingernails and toenails that can lead to discomfort, chronic pain and disfigurement. Proximal subungual, white superficial and distal subungual are some of the types of onychomycosis. It is a common nail infection in patients with athlete's foot and is caused by various organisms, such as dermatophytes, yeasts and non-dermatophyte molds. Onychomycosis is characterized by symptoms, including distortion in the shape of nails, foul smell, whitish to yellow-brown discoloration and brittle, ragged and crumbly texture of the nails. It is usually diagnosed through potassium, oxygen and hydrogen (KOH) examination, culture and histopathological examinations of nail clippings and nail biopsies and is treated through laser therapy, drugs and photodynamic therapies.

Onychomycosis Treatment Market Trends:

The increasing prevalence of chronic medical ailments, such as onychomycosis, human immunodeficiency virus (HIV), diabetes and peripheral artery disease (PAD), is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is highly prone to circulatory disorders and weakened immune system, is providing a thrust to the market growth. Onychomycosis is also highly prevalent among millennials and adults due to the increased exposure to public swimming pools and utilization of tight, contaminated or soiled clothes, shoes and socks. Additionally, the development of water-soluble antifungal treatment solutions that can be administered orally is providing a thrust to the market growth. They aid in preventing secondary bacterial infections and prevent the growth of fungus. Other factors, including the widespread utilization of topical nail lacquers and ointments to maintain nail hygiene, along with the significant improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.

Key Market Segmentation:

Breakup by Disease Type:

  • Distal Subungual Onychomycosis
  • Proximal Subungual Onychomycosis
  • White Superficial Onychomycosis
  • Candidal Onychomycosis
  • Others

Breakup by Treatment Type:

  • Laser Therapy
  • Photodynamic Therapy
  • Drug Treatment

Breakup by Drug Class:

  • Allylamine
  • Azole
  • Griseofulvin
  • Others

Breakup by Distribution Channel:

  • Hospitals and Clinics
  • Online Stores
  • Retail Pharmacies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Bausch Health Companies Inc., Cipla Limited, Dr. Reddy's Laboratories, Galderma SA, GlaxoSmithKline PLC, Kaken Pharmaceutical Co. Ltd, Lumenis Ltd, Moberg Pharma AB, Novartis AG, Pfizer Inc. and The OTC Lab B.V.

Key Questions Answered in This Report

  • 1.What was the size of the global onychomycosis treatment market in 2024?
  • 2.What is the expected growth rate of the global onychomycosis treatment market during 2025-2033?
  • 3.What are the key factors driving the global onychomycosis treatment market?
  • 4.What has been the impact of COVID-19 on the global onychomycosis treatment market?
  • 5.What is the breakup of the global onychomycosis treatment market based on the disease type?
  • 6.What is the breakup of the global onychomycosis treatment market based on the treatment type?
  • 7.What is the breakup of the global onychomycosis treatment market based on the distribution channel?
  • 8.What are the key regions in the global onychomycosis treatment market?
  • 9.Who are the key players/companies in the global onychomycosis treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Onychomycosis Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Disease Type

  • 6.1 Distal Subungual Onychomycosis
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Proximal Subungual Onychomycosis
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 White Superficial Onychomycosis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Candidal Onychomycosis
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Treatment Type

  • 7.1 Laser Therapy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Photodynamic Therapy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Drug Treatment
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Drug Class

  • 8.1 Allylamine
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Azole
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Griseofulvin
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Online Stores
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Retail Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Bausch Health Companies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Cipla Limited
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Dr. Reddy's Laboratories
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Galderma SA
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 GlaxoSmithKline PLC
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Kaken Pharmaceutical Co. Ltd
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Lumenis Ltd
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 SWOT Analysis
    • 15.3.8 Moberg Pharma AB
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Novartis AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 The OTC Lab B.V.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Onychomycosis Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Onychomycosis Treatment Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Onychomycosis Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Onychomycosis Treatment Market: Breakup by Disease Type (in %), 2024
  • Figure 5: Global: Onychomycosis Treatment Market: Breakup by Treatment Type (in %), 2024
  • Figure 6: Global: Onychomycosis Treatment Market: Breakup by Drug Class (in %), 2024
  • Figure 7: Global: Onychomycosis Treatment Market: Breakup by Distribution Channel (in %), 2024
  • Figure 8: Global: Onychomycosis Treatment Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Onychomycosis Treatment (Distal Subungual Onychomycosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Onychomycosis Treatment (Distal Subungual Onychomycosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Onychomycosis Treatment (Proximal Subungual Onychomycosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Onychomycosis Treatment (Proximal Subungual Onychomycosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Onychomycosis Treatment (White Superficial Onychomycosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Onychomycosis Treatment (White Superficial Onychomycosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Onychomycosis Treatment (Candidal Onychomycosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Onychomycosis Treatment (Candidal Onychomycosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Onychomycosis Treatment (Other Disease Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Onychomycosis Treatment (Other Disease Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Onychomycosis Treatment (Laser Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Onychomycosis Treatment (Laser Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Onychomycosis Treatment (Photodynamic Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Onychomycosis Treatment (Photodynamic Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Onychomycosis Treatment (Drug Treatment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Onychomycosis Treatment (Drug Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Onychomycosis Treatment (Allylamine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Onychomycosis Treatment (Allylamine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Onychomycosis Treatment (Azole) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Onychomycosis Treatment (Azole) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Onychomycosis Treatment (Griseofulvin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Onychomycosis Treatment (Griseofulvin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Onychomycosis Treatment (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Onychomycosis Treatment (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Onychomycosis Treatment (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Onychomycosis Treatment (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Onychomycosis Treatment (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Onychomycosis Treatment (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Onychomycosis Treatment (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Onychomycosis Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Onychomycosis Treatment (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Onychomycosis Treatment (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: North America: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: North America: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: United States: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: United States: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Canada: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Canada: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Asia-Pacific: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Asia-Pacific: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: China: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: China: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Japan: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Japan: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: India: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: India: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: South Korea: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: South Korea: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Australia: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Australia: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Indonesia: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Indonesia: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Others: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Others: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Europe: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Europe: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Germany: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Germany: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: France: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: France: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: United Kingdom: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: United Kingdom: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Italy: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Italy: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Spain: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Spain: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Russia: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Russia: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Others: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Others: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Latin America: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Latin America: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Brazil: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Brazil: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Mexico: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Mexico: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Others: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Others: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Middle East and Africa: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Middle East and Africa: Onychomycosis Treatment Market: Breakup by Country (in %), 2024
  • Figure 89: Middle East and Africa: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 90: Global: Onychomycosis Treatment Industry: SWOT Analysis
  • Figure 91: Global: Onychomycosis Treatment Industry: Value Chain Analysis
  • Figure 92: Global: Onychomycosis Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Onychomycosis Treatment Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Onychomycosis Treatment Market Forecast: Breakup by Disease Type (in Million USD), 2025-2033
  • Table 3: Global: Onychomycosis Treatment Market Forecast: Breakup by Treatment Type (in Million USD), 2025-2033
  • Table 4: Global: Onychomycosis Treatment Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
  • Table 5: Global: Onychomycosis Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 6: Global: Onychomycosis Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Onychomycosis Treatment Market: Competitive Structure
  • Table 8: Global: Onychomycosis Treatment Market: Key Players